Get 20% Free Customization In This Report

Buy this report from - $3456

Serological Transplant Diagnostics Market by Product Type [Reagents and Accessories Systems] by Application [Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Pancreas Transplantation and Other Transplantations] by End User [Hospitals, Blood Banks, Transplant Centers, Donor Registries and Research Laboratories] - Global Opportunity Analysis and Industry Forecast, 2017-2023

Medical Devices & Supplies	LI_183900	Pages: NA	Jun 2018 \| 435 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Human leukocyte antigens (HLA) are molecules, which are found on cell surfaces that control how the body identifies a situation and thus possibly discards foreign tissue transplants. Hence, the serological transplant was introduced that reduces the effect of HLA matching; a transplant can be done successfully with minimum HLA matching criteria. Key factors that drive the growth of this market are the rise in transplantations caused due to various reasons as well as an increase in awareness related to serological transplantations. However, the high costs related to serological transplantations and unfavorable reimbursement scenario especially in developing economies will impede the market growth. Moreover, advancements in technology in the field of organ transplantation will create more lucrative opportunities for key market players globally.

The serological transplant diagnostics market is segmented based on product type, application, end user, and geography. Based on product type this market is segmented into reagents and accessories systems. Based on applications this market is segmented into kidney transplantation, liver transplantation, heart transplantation, lung transplantation, pancreas transplantation, and other transplantations. Based on end user this market is segmented into hospitals, blood banks, transplant centers, donor registries, and research laboratories. By geography, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Bio-Rad Laboratories, Immucor, Inc., Siemens Healthineers, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Agena Bioscience, Avioq, Inc., BAG Health Care GmbH, Becton, Dickinson and Company and Beckman Coulter Inc. have also been provided in this report.

Key Benefits

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global serological transplant diagnostics market.
In-depth analysis has been carried out in this report by constructing market estimations for key market segments between 2016 and 2023.
Geographically, the global serological transplant diagnostics market has been analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA.
This study that evaluates the competitive landscape and value chain has been taken into account to help understand the competitive environment globally.
Comprehensive analysis of factors that drive and restrict the growth of the global serological transplant diagnostics market has been provided.
This report provides the quantitative analysis of the current market and estimations from 2016-2023, which assists in identifying prevailing market opportunities
Comprehensive analysis of all regions has been provided that determines prevailing opportunities in these geographies.

Serological Transplant Diagnostics Market Key Segments:

By Product Type

Reagents
Accessories Systems

By Applications

Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation
Other Transplantations

By End User

Hospitals
Blood Banks
Transplant Centers
Donor Registries
Research Laboratories

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- U.K
- France
- Germany
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Australia
- Japan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 SEROLOGICAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. REAGENTS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. ACCESSORIES SYSTEMS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 SEROLOGICAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. KIDNEY TRANSPLANTATION

5.2.1. Market size and forecast

5.3. LIVER TRANSPLANTATION

5.3.1. Market size and forecast

5.4. HEART TRANSPLANTATION

5.4.1. Market size and forecast

5.5. LUNG TRANSPLANTATION

5.5.1. Market size and forecast

5.6. PANCREAS TRANSPLANTATION

5.6.1. Market size and forecast

5.7. OTHER TRANSPLANTATION

5.7.1. Market size and forecast

Chapter: 6 SEROLOGICAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. BLOOD BANKS

6.3.1. Market size and forecast

6.4. TRANSPLANT CENTERS

6.4.1. Market size and forecast

6.5. DONOR REGISTRIES

6.5.1. Market size and forecast

6.6. RESEARCH LABORATORIES

6.6.1. Market size and forecast

Chapter: 7 SEROLOGICAL TRANSPLANT DIAGNOSTICS MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.2.4. North America Serological Transplant Diagnostics Market by Product Type
7.2.5. North America Serological Transplant Diagnostics Market by Application
7.2.6. North America Serological Transplant Diagnostics Market by End User

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Spain market size and forecast
7.3.3.5. Rest of Europe market size and forecast

7.3.4. Europe Serological Transplant Diagnostics Market by Product Type
7.3.5. Europe Serological Transplant Diagnostics Market by Application
7.3.6. Europe Serological Transplant Diagnostics Market by End User

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. Rest of Asia-Pacific market size and forecast

7.4.4. Asia-Pacific Serological Transplant Diagnostics Market by Product Type
7.4.5. Asia-Pacific Serological Transplant Diagnostics Market by Application
7.4.6. Asia-Pacific Serological Transplant Diagnostics Market by End User

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. South Africa market size and forecast
7.5.3.5. Rest of LAMEA market size and forecast

7.5.4. LAMEA Serological Transplant Diagnostics Market by Product Type
7.5.5. LAMEA Serological Transplant Diagnostics Market by Application
7.5.6. LAMEA Serological Transplant Diagnostics Market by End User

Chapter: 8 COMPANY PROFILES

8.1. BIO-RAD LABORATORIES

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. IMMUCOR, INC.

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. SIEMENS HEALTHINEERS

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. ORTHO CLINICAL DIAGNOSTICS

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. THERMO FISHER SCIENTIFIC

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. AGENA BIOSCIENCE

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. AVIOQ, INC.

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. BAG HEALTH CARE GMBH

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. BECTON, DICKINSON AND COMPANY

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. BECKMAN COULTER INC.

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.